-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...

-The Telegraph Bhubaneswar (Odisha): The Centre-sponsored Jan Aushadhi scheme is suffering from shortage of medicines and reluctance of doctors to prescribe drugs by their generic names. The scheme, which is being run by the Odisha branch of the Indian Red Cross Society in 22 districts of the state, was launched to sell quality generic medicines at subsidised prices. Though the city has two Jan Aushadhi stores, chances are that you will have to...

-The Times of India MUMBAI: For the first time ever, some of India's biggest pharmaceutical companies, cutting across their respective associations and representing nearly half the Rs 93,000 crore market, have come together to push for ethical marketing practices to clean up the industry's image. The forum, comprising of 40 to 50 domestic and MNC firms, had its first closed-door meeting on October 14. It has made a "voluntary and moral commitment"...

-Outlook Scientist and longtime activist against genetically modified BT seeds, Dr. Vandana Shiva, talks about why BT has a devastating fallout. A sudden pest attack has ruined cotton crops in large parts of Punjab, bringing biotech, or BT Cotton back into focus. Farmers who used bio-fertilisers in the Malwa region of the state are said to be safe from this latest pestilence. But those growing BT cotton have lost everything. There...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...